<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03727360</url>
  </required_header>
  <id_info>
    <org_study_id>1115946</org_study_id>
    <secondary_id>1R01AG057552</secondary_id>
    <nct_id>NCT03727360</nct_id>
  </id_info>
  <brief_title>Exercise for Brain Health in the Fight Against Alzheimer's Disease</brief_title>
  <official_title>Exercise for Brain Health in the Fight Against Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland, College Park</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Marquette University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland, College Park</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to compare the effects of a 6-month moderate intensity exercise
      training (ET) intervention to a low intensity flexibility exercise control condition (FC) on
      brain function, cognition, and physical function in cognitively healthy and physically
      inactive older adults (ages 60-80). Apolipoprotein E epsilon4 (APOE-ε4) allele carriers are
      known to be at substantially greater risk for cognitive decline and Alzheimer's disease (AD).
      Cognitively intact APOE-ε4 allele carriers, and non-carriers, will be randomly assigned to
      6-months of either supervised moderate intensity aerobic exercise training (ET) or supervised
      flexibility exercise control (FC). The ET and FC each contain a group based exercise
      component and are run in local retirement communities near College Park, MD, or on the
      University of Maryland College Park campus. The primary aims of the study are to compare
      pre-intervention to post-intervention changes in episodic memory performance and MRI
      biomarkers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 8, 2018</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Participants and outcomes assessors are masked to APOE genotype. We do not share any data with care providers.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline to 6 months in Rey Auditory Verbal Learning Test Sum of Trials 1-5</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline to 6 months in Resting Cerebral Blood Flow</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline to 6 months in VO2peak</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Estimated peak rate of oxygen consumption, a measure of cardiorespiratory fitness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline to 6 months in 6 Minute Walk Test</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Distance walked in 6 minutes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Healthy Cognition</condition>
  <arm_group>
    <arm_group_label>Exercise Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group exercise and treadmill walking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flexibility Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group exercise and flexibility exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise Training</intervention_name>
    <description>Supervised exercise conducted four days per week for six months.</description>
    <arm_group_label>Exercise Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flexibility Control</intervention_name>
    <description>Supervised exercise conducted four days per week for six months.</description>
    <arm_group_label>Flexibility Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 to 80 years old

          -  Fluent in English

          -  Willingness to make the time commitment to participate in the project, including
             randomization to treatments

          -  Physically inactive (physical activity not more than 2 days per week for the past 6
             months)

          -  Physician consent to undergo an exercise stress test and engage in moderate intensity
             exercise

          -  Determined to be safe for MRI

        Exclusion Criteria:

          -  Neurological illnesses/conditions such as cerebral palsy, epi¬lepsy, brain tumor,
             chronic meningitis, multiple scle¬rosis, pernicious anemia, normal-pressure
             hydrocephalus, HIV infection, Parkinson's disease, and Huntington's disease

          -  Untreated hypertension, glaucoma, and chronic obstructive pul¬monary disease

          -  Untreated severe major depression

          -  Substance abuse or dependence

          -  Current use of psychoactive medications, except selective serotonin/norepinephrine
             reuptake inhibitor antidepressants

          -  Use of acetylcholinesterase inhibitors (e.g., Aricept)

          -  Unstable or severe cardiovascular disease or asthmatic condition

          -  History of transient ischemic attack, cerebral ischemia, or clinically diagnosed
             stroke

          -  Diagnosis of mild cognitive impairment or dementia, or objective evidence of cognitive
             impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Carson Smith, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland, College Park</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Coordinator</last_name>
    <phone>301-405-2574</phone>
    <email>exercisebrainhealth@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Maryland, Department of Kinesiology</name>
      <address>
        <city>College Park</city>
        <state>Maryland</state>
        <zip>20742</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>301-405-2574</phone>
      <email>exercisebrainhealth@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 26, 2018</study_first_submitted>
  <study_first_submitted_qc>October 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2018</study_first_posted>
  <last_update_submitted>October 30, 2018</last_update_submitted>
  <last_update_submitted_qc>October 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Walking Exercise</keyword>
  <keyword>Flexibility Exercise</keyword>
  <keyword>Cognition</keyword>
  <keyword>Memory</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

